Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Apolipoprotein B and platelet function in diabetes mellitus
Pathophysiology of Haemostasis and Thrombosis, Volume 16, No. 6, Year 1986
Notification
URL copied to clipboard!
Description
Serum levels of apolipoprotein Β were measured, and investigations of the platelet function were carried out in 32 patients with insulin-dependent dabetes and in 34 healthy controls similar in age. Mean scrum levels of apolipoprotein Β were 1.51 g/l in the diabetic patients and 1.18 g/l in the control group, and this difference was significant. In the diabetic patients a secondary wave of aggregation was more easily induced by low concentrations of adenosine diphosphate or adrenaline. It was also possible to induce 50% of maximal aggregation by lower concentrations of adenosine diphosphate or arachidonic acid in these patients, and their number of circulating platelet aggregates increased. Plasma levels of β-thromboglobulin and platelet factor 4 were raised and, in the presence of N-ethyl maleimide, platelets from diabetic patients produced significantly more malondialdehyde than those from normal controls. The relationship between increased scrum levels of apolipoprotein Β and platelet hyperreactivity may be more than accidental and should be studied further to elucidate its possible implication with platelet function and atherogenesis. © 1986 S. Karger AG, Basel.
Authors & Co-Authors
Kubisz, Peter
Slovakia, Trencin
General Hospital, Trencin
Algeria, Oran
Centre Hospitalier - Universitaire D'oran
Parizek, M.
Slovakia, Trencin
General Hospital, Trencin
Cronberg, Stig N.
Slovakia, Trencin
General Hospital, Trencin
Statistics
Citations: 3
Authors: 3
Affiliations: 2
Identifiers
Doi:
10.1159/000215319
ISSN:
14248832
Research Areas
Noncommunicable Diseases
Study Design
Randomised Control Trial